A.F. Navarro Mendivil

机构：Hospital Clínic de Barcelona

发表论文 21 篇 · 总被引 51 次 · h-index 4

代表论文

LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial (2024 · Annals of Oncology · 被引 14)
1989MO Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study (2023 · Annals of Oncology · 被引 10)
1786O BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study (2024 · Annals of Oncology · 被引 7)
297MO: Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC (2025 · Journal of Thoracic Oncology · 被引 6)
1806P Final safety and efficacy data from CLEPSIDRA trial in 2L ED-SCLC (2020 · Annals of Oncology · 被引 4)
2792TiP A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC) (2025 · Annals of Oncology · 被引 2)